TY  - GEN
AU  - Nowak-Göttl,Ulrike
AU  - Dietrich,Kevin
AU  - Schaffranek,Daria
AU  - Eldin,Noha Sharaf
AU  - Yasui,Yutaka
AU  - Geisen,Christof
AU  - Mitchell,Lesley G
TI  - In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes
SN  - 1528-0020
PY  - 2011///0222
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Anticoagulants
KW  - administration & dosage
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Child
KW  - Child, Preschool
KW  - Cohort Studies
KW  - Cytochrome P-450 CYP2C9
KW  - Genotype
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Mixed Function Oxygenases
KW  - Phenprocoumon
KW  - Polymorphism, Genetic
KW  - Prognosis
KW  - Prospective Studies
KW  - Thrombosis
KW  - drug therapy
KW  - Vitamin K
KW  - antagonists & inhibitors
KW  - Vitamin K Epoxide Reductases
KW  - Warfarin
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2010-05-283861
ER  -